Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenylketonurias | 2 | 2019 | 15 | 1.040 |
Why?
|
| Neurodevelopmental Disorders | 5 | 2025 | 227 | 0.740 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 369 | 0.710 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2019 | 1 | 0.610 |
Why?
|
| Neonatal Screening | 2 | 2019 | 179 | 0.610 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 115 | 0.490 |
Why?
|
| Nerve Tissue Proteins | 3 | 2025 | 591 | 0.460 |
Why?
|
| Genotype | 2 | 2019 | 1852 | 0.440 |
Why?
|
| Phenotype | 5 | 2024 | 3155 | 0.430 |
Why?
|
| Intellectual Disability | 4 | 2025 | 179 | 0.420 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 777 | 0.350 |
Why?
|
| Mutation | 5 | 2021 | 4075 | 0.350 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 530 | 0.340 |
Why?
|
| Exome | 2 | 2023 | 227 | 0.320 |
Why?
|
| Autism Spectrum Disorder | 2 | 2023 | 422 | 0.250 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2024 | 1 | 0.210 |
Why?
|
| Eye Proteins | 1 | 2024 | 92 | 0.200 |
Why?
|
| Visual Fields | 1 | 2024 | 116 | 0.200 |
Why?
|
| Microcephaly | 1 | 2024 | 104 | 0.200 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 32 | 0.180 |
Why?
|
| Alleles | 3 | 2020 | 894 | 0.180 |
Why?
|
| Intracranial Hypertension | 1 | 2022 | 42 | 0.180 |
Why?
|
| Symporters | 1 | 2022 | 48 | 0.180 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 271 | 0.170 |
Why?
|
| Synapses | 1 | 2025 | 439 | 0.170 |
Why?
|
| Myopia, Degenerative | 1 | 2021 | 5 | 0.170 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 15 | 0.170 |
Why?
|
| RNA Helicases | 1 | 2021 | 27 | 0.170 |
Why?
|
| Semaphorins | 1 | 2021 | 37 | 0.170 |
Why?
|
| Visual Acuity | 1 | 2024 | 491 | 0.160 |
Why?
|
| Graves Disease | 1 | 2020 | 32 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2023 | 219 | 0.160 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 27 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 181 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 56 | 0.160 |
Why?
|
| Retinal Diseases | 1 | 2021 | 101 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2020 | 27 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2024 | 1164 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 45 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 456 | 0.150 |
Why?
|
| Conserved Sequence | 1 | 2020 | 244 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 372 | 0.150 |
Why?
|
| Dicarboxylic Acid Transporters | 1 | 2018 | 2 | 0.140 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2018 | 11 | 0.140 |
Why?
|
| Alopecia | 1 | 2018 | 37 | 0.140 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 46 | 0.140 |
Why?
|
| Megalencephaly | 1 | 2018 | 20 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 35 | 0.140 |
Why?
|
| Genetic Loci | 1 | 2020 | 264 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 302 | 0.140 |
Why?
|
| Cataract | 1 | 2021 | 238 | 0.140 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2018 | 5 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2018 | 146 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2019 | 6447 | 0.120 |
Why?
|
| Disease Resistance | 1 | 2016 | 29 | 0.120 |
Why?
|
| Mutation, Missense | 3 | 2024 | 335 | 0.120 |
Why?
|
| Syndrome | 2 | 2025 | 381 | 0.100 |
Why?
|
| Humans | 17 | 2025 | 145474 | 0.100 |
Why?
|
| Loss of Function Mutation | 2 | 2024 | 45 | 0.100 |
Why?
|
| Male | 12 | 2025 | 72842 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2378 | 0.090 |
Why?
|
| United States | 2 | 2019 | 16098 | 0.080 |
Why?
|
| Retina | 2 | 2024 | 326 | 0.080 |
Why?
|
| Child | 7 | 2024 | 22707 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2024 | 11853 | 0.060 |
Why?
|
| Infant | 4 | 2024 | 10077 | 0.060 |
Why?
|
| Female | 6 | 2025 | 78844 | 0.050 |
Why?
|
| Dark Adaptation | 1 | 2024 | 13 | 0.050 |
Why?
|
| Retinal Dystrophies | 1 | 2024 | 4 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 11772 | 0.050 |
Why?
|
| Visual Field Tests | 1 | 2024 | 32 | 0.050 |
Why?
|
| Glycogen | 1 | 2023 | 55 | 0.050 |
Why?
|
| Protein Phosphatase 1 | 1 | 2023 | 32 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2025 | 292 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2025 | 207 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 22529 | 0.050 |
Why?
|
| Hemizygote | 1 | 2022 | 5 | 0.050 |
Why?
|
| Maternal Inheritance | 1 | 2022 | 15 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2025 | 326 | 0.040 |
Why?
|
| Heterozygote | 1 | 2023 | 313 | 0.040 |
Why?
|
| Mydriatics | 1 | 2021 | 10 | 0.040 |
Why?
|
| Tetraspanins | 1 | 2021 | 18 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2022 | 234 | 0.040 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2020 | 9 | 0.040 |
Why?
|
| Thyroxine | 1 | 2020 | 66 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2020 | 44 | 0.040 |
Why?
|
| Animals | 4 | 2025 | 38030 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2020 | 92 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 199 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 333 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 407 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 176 | 0.040 |
Why?
|
| Pedigree | 1 | 2021 | 515 | 0.040 |
Why?
|
| Hippocampus | 1 | 2025 | 971 | 0.040 |
Why?
|
| Protein Folding | 1 | 2020 | 276 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 22 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 177 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 238 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 741 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 263 | 0.030 |
Why?
|
| Glucose | 1 | 2023 | 1048 | 0.030 |
Why?
|
| Brain | 2 | 2022 | 2947 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2022 | 1707 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1716 | 0.030 |
Why?
|
| Zebrafish | 1 | 2021 | 532 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 1649 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2018 | 297 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 14218 | 0.030 |
Why?
|
| Mice | 2 | 2025 | 18329 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 114 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 561 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5423 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 1134 | 0.020 |
Why?
|
| Aging | 1 | 2024 | 1969 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2158 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 4295 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 5216 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17291 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 40777 | 0.010 |
Why?
|